Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription Articles published in Science Retrieve available abstracts of 111 articles: HTML format

Single Articles

March 2024
1. MICHEL AL
   Vaccines to control tuberculosis in cattle.
   Science. 2024;383:1410-1411.
   PubMed     Abstract available
   
   
   
2. FROMSA A, Willgert K, Srinivasan S, Mekonnen G, et al
   BCG vaccination reduces bovine tuberculosis transmission, improving prospects for elimination.
   Science. 2024;383:eadl3962.
   PubMed     Abstract available
   
   
   
3. TRIUNFOL M
   Brazil is hoping and waiting for a new vaccine as dengue rages.
   Science. 2024;383:1042-1043.
   PubMed     Abstract available
   
   
   
4. COHEN J
   Skin side effects stymie advance of HIV vaccine.
   Science. 2024;383:1044.
   PubMed     Abstract available
   
   
   
5. PAWAR P
   World's cholera vaccine stash is empty-but relief is on its way.
   Science. 2024;383:939-940.
   PubMed     Abstract available
   
   
   December 2023
6. MIGUELES SA, Nettere DM, Gavil NV, Wang LT, et al
   HIV vaccines induce CD8(+) T cells with low antigen receptor sensitivity.
   Science. 2023;382:1270-1276.
   PubMed     Abstract available
   
   
   November 2023
7. COHEN J
   A chikungunya vaccine is likely to get approved. Who will get it?
   Science. 2023;382:503-504.
   PubMed     Abstract available
   
   
   October 2023
8. WADMAN M
   First malaria vaccine slashes childhood deaths.
   Science. 2023;382:357.
   PubMed     Abstract available
   
   
   
9. COHEN J
   Billions boost next-generation weapons against SARS-CoV-2.
   Science. 2023;382:359-360.
   PubMed     Abstract available
   
   
   
10. KRAMMER F, Ellebedy AH
    Variant-adapted COVID-19 booster vaccines.
    Science. 2023;382:157-159.
    PubMed     Abstract available
    
    
    
11. COUZIN-FRANKEL J
    New Novavax vaccine OK'd; studies size it up against mRNA.
    Science. 2023;382:141-142.
    PubMed     Abstract available
    
    
    
12. VOGEL G
    Second malaria vaccine gets WHO green light.
    Science. 2023;382:16-17.
    PubMed     Abstract available
    
    
    
13. OFFORD C, Cohen J
    Award honors pair for mRNA work key to COVID-19 vaccines.
    Science. 2023;382:22.
    PubMed     Abstract available
    
    
    September 2023
14. GOLDMAN MA
    Pandemics and their lessonsForeign Bodies: Pandemics, Vaccines, and the Health of Nations Simon Schama Ecco, 2023. 480 pp.
    Science. 2023;381:1418.
    PubMed     Abstract available
    
    
    July 2023
15. COHEN J
    Childhood vaccine crusader shares concerns for future.
    Science. 2023;381:365.
    PubMed     Abstract available
    
    
    
16. VOGEL G, Couzin-Frankel J
    Studies probe COVID-19 shots' link to rare symptoms.
    Science. 2023;381:18-19.
    PubMed     Abstract available
    
    
    June 2023
17. COHEN J
    Companies hoard COVID-19 vaccines, stalling future research.
    Science. 2023;380:1001-1002.
    PubMed     Abstract available
    
    
    May 2023
18. COUZIN-FRANKEL J
    Decision nears for fall coronavirus vaccine.
    Science. 2023;380:784.
    PubMed     Abstract available
    
    
    
19. LAVERY JV, Porter RM, Addiss DG
    Cascading failures in COVID-19 vaccine equity.
    Science. 2023;380:460-462.
    PubMed     Abstract available
    
    
    April 2023
20. KAISER J
    Tailored melanoma vaccine may stave off cancer.
    Science. 2023;380:232.
    PubMed     Abstract available
    
    
    
21. OFFERSGAARD A, Bukh J, Gottwein JM
    Toward a vaccine against hepatitis C virus.
    Science. 2023;380:37-38.
    PubMed     Abstract available
    
    
    March 2023
22. CHUBATSU NUNES HH, Dang TT
    A booster for vaccines from plants.
    Science. 2023;379:1187-1188.
    PubMed     Abstract available
    
    
    
23. VOGEL G
    Do COVID-19 vaccine mandates still make sense?
    Science. 2023;379:1072-1073.
    PubMed     Abstract available
    
    
    February 2023
24. NORMILE D
    Japan moves to bolster its vaccine R&D sector.
    Science. 2023;379:627.
    PubMed     Abstract available
    
    
    
25. COUZIN-FRANKEL J
    New COVID-19 vaccine strategy would mimic flu's annual shots.
    Science. 2023;379:425-426.
    PubMed     Abstract available
    
    
    January 2023
26. KALIA A, Hickman HD
    A vaccine sanctuary in the lymph node.
    Science. 2023;379:332-333.
    PubMed     Abstract available
    
    
    December 2022
27. VOGEL G
    Pandemic vaccine equity plan may soon start winding down.
    Science. 2022;378:1158-1159.
    PubMed     Abstract available
    
    
    
28. MOORE PL
    Triggering rare HIV antibodies by vaccination.
    Science. 2022;378:949-950.
    PubMed     Abstract available
    
    
    
29. LEGGAT DJ, Cohen KW, Willis JR, Fulp WJ, et al
    Vaccination induces HIV broadly neutralizing antibody precursors in humans.
    Science. 2022;378:eadd6502.
    PubMed     Abstract available
    
    
    
30. KUPFERSCHMIDT K
    Vaccines are in short supply amid global cholera surge.
    Science. 2022;378:938-939.
    PubMed     Abstract available
    
    
    November 2022
31. KELVIN AA, Falzarano D
    The influenza universe in an mRNA vaccine.
    Science. 2022;378:827-828.
    PubMed     Abstract available
    
    
    
32. AREVALO CP, Bolton MJ, Le Sage V, Ye N, et al
    A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.
    Science. 2022;378:899-904.
    PubMed     Abstract available
    
    
    
33. MALE V
    COVID-19 vaccination and menstruation.
    Science. 2022;378:704-706.
    PubMed     Abstract available
    
    
    October 2022
34. COHEN J
    Forgotten Ebola vaccine could help in outbreak.
    Science. 2022;378:340-341.
    PubMed     Abstract available
    
    
    
35. MAO T, Israelow B, Pena-Hernandez MA, Suberi A, et al
    Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses.
    Science. 2022 Oct 27:eabo2523. doi: 10.1126/science.abo2523.
    PubMed     Abstract available
    
    
    
36. TORRENTS DE LA PENA A, Sliepen K, Eshun-Wilson L, Newby ML, et al
    Structure of the hepatitis C virus E1E2 glycoprotein complex.
    Science. 2022;378:263-269.
    PubMed     Abstract available
    
    
    
37. COUZIN-FRANKEL J
    Heart risks fuel debate over COVID-19 boosters.
    Science. 2022;378:234-235.
    PubMed     Abstract available
    
    
    
38. COHEN J
    Uganda's Ebola outbreak will put novel vaccines to the test.
    Science. 2022;378:14-15.
    PubMed     Abstract available
    
    
    September 2022
39. VOGEL G
    New Omicron strains may portend big COVID-19 waves.
    Science. 2022;377:1479.
    PubMed     Abstract available
    
    
    August 2022
40. WHERRY EJ, Barouch DH
    T cell immunity to COVID-19 vaccines.
    Science. 2022;377:821-822.
    PubMed     Abstract available
    
    
    
41. KUPFERSCHMIDT K
    Scientists scramble to set up monkeypox vaccine trials.
    Science. 2022;377:696-697.
    PubMed     Abstract available
    
    
    
42. COHEN J
    Making broader coronavirus vaccines is a struggle.
    Science. 2022;377:566-567.
    PubMed     Abstract available
    
    
    July 2022
43. DOLGIN E
    The ascent of ModernaThe Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World Peter Loftus Harvard Business Review Press, 2022. 320 pp.
    Science. 2022;377:479.
    PubMed     Abstract available
    
    
    
44. BOWEN JE, Addetia A, Dang HV, Stewart C, et al
    Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.
    Science. 2022 Jul 19:eabq0203. doi: 10.1126/science.abq0203.
    PubMed     Abstract available
    
    
    
45. CHEN R, Guo X, Zhu A
    Vaccinate to combat COVID-19 in China.
    Science. 2022;377:271.
    PubMed    
    
    
    
46. DACON C, Tucker C, Peng L, Lee CD, et al
    Broadly neutralizing antibodies target the coronavirus fusion peptide.
    Science. 2022 Jul 12:eabq3773. doi: 10.1126/science.abq3773.
    PubMed     Abstract available
    
    
    June 2022
47. REYNOLDS CJ, Pade C, Gibbons JM, Otter AD, et al
    Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure.
    Science. 2022 Jun 14:eabq1841. doi: 10.1126/science.abq1841.
    PubMed     Abstract available
    
    
    
48. KUPFERSCHMIDT K
    Monkeypox vaccination plans take shape amid questions.
    Science. 2022;376:1142-1143.
    PubMed     Abstract available
    
    
    May 2022
49. STOKSTAD E
    Wrestling with bird flu, Europe considers once-taboo vaccines.
    Science. 2022;376:682-683.
    PubMed     Abstract available
    
    
    
50. DOLGIN E
    Better lipids to power next generation of mRNA vaccines.
    Science. 2022;376:680-681.
    PubMed     Abstract available
    
    
    
51. VOGEL G
    New subvariants are masters of immune evasion.
    Science. 2022;376:679-680.
    PubMed     Abstract available
    
    
    April 2022
52. COHEN J
    First self-copying mRNA vaccine proves itself in pandemic trial.
    Science. 2022;376:446.
    PubMed     Abstract available
    
    
    
53. PULLA P
    India's speedy vaccine approvals come under fire.
    Science. 2022;376:442-443.
    PubMed     Abstract available
    
    
    
54. ARINAMINPATHY N, Saad-Roy CM, Yang Q, Ahmad I, et al
    A global system for the next generation of vaccines.
    Science. 2022;376:462-464.
    PubMed     Abstract available
    
    
    
55. COUZIN-FRANKEL J
    Global project gears up to study vaccine safety.
    Science. 2022;376:227-228.
    PubMed     Abstract available
    
    
    
56. COHEN J
    New crop of mRNA vaccines aim for accessibility.
    Science. 2022;376:120-121.
    PubMed     Abstract available
    
    
    
57. NORMILE D
    Japan reboots HPV vaccination drive after 9-year gap.
    Science. 2022;376:14.
    PubMed     Abstract available
    
    
    March 2022
58. LENTZOS F, Rybicki EP, Engelhard M, Paterson P, et al
    Self-spreading vaccines: Base policy on evidence-Response.
    Science. 2022;375:1363.
    PubMed    
    
    
    
59. STREICKER DG, Bull JJ, Nuismer SL
    Self-spreading vaccines: Base policy on evidence.
    Science. 2022;375:1362-1363.
    PubMed    
    
    
    
60. DEAN NE, Halloran ME
    Protecting the herd with vaccination.
    Science. 2022;375:1088-1089.
    PubMed     Abstract available
    
    
    
61. ALTMANN DM, Boyton RJ
    COVID-19 vaccination: The road ahead.
    Science. 2022;375:1127-1132.
    PubMed     Abstract available
    
    
    
62. EDWARDS AM, Baric RS, Saphire EO, Ulmer JB, et al
    Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
    Science. 2022;375:1133-1139.
    PubMed     Abstract available
    
    
    
63. KOELLE K, Martin MA, Antia R, Lopman B, et al
    The changing epidemiology of SARS-CoV-2.
    Science. 2022;375:1116-1121.
    PubMed     Abstract available
    
    
    
64. MOBARAK AM, Miguel E, Abaluck J, Ahuja A, et al
    End COVID-19 in low- and middle-income countries.
    Science. 2022;375:1105-1110.
    PubMed    
    
    
    
65. ROBERTS L
    Africa battles out-of-control polio outbreaks.
    Science. 2022;375:1079-1080.
    PubMed     Abstract available
    
    
    February 2022
66. BIERING SB
    One antibody to treat them all.
    Science. 2022;375:803.
    PubMed     Abstract available
    
    
    
67. ROURKE M, Eccleston-Turner M, Switzer S
    Sovereignty, sanctions, and data sharing under international law.
    Science. 2022;375:724-726.
    PubMed     Abstract available
    
    
    
68. KAKU CI, Champney ER, Normark J, Garcia M, et al
    Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination.
    Science. 2022 Feb 10:eabn2688. doi: 10.1126/science.abn2688.
    PubMed     Abstract available
    
    
    
69. ELLIOTT P, Bodinier B, Eales O, Wang H, et al
    Rapid increase in Omicron infections in England during December 2021: REACT-1 study.
    Science. 2022 Feb 8:eabn8347. doi: 10.1126/science.abn8347.
    PubMed     Abstract available
    
    
    
70. WADMAN M
    New Omicron begins to take over, despite late start.
    Science. 2022;375:480-481.
    PubMed     Abstract available
    
    
    January 2022
71. COUZIN-FRANKEL J, Vogel G
    Vaccines may cause rare, Long Covid-like symptoms.
    Science. 2022;375:364-366.
    PubMed     Abstract available
    
    
    
72. KUPFERSCHMIDT K
    After Omicron, some scientists foresee 'a period of quiet'.
    Science. 2022;375:366-367.
    PubMed     Abstract available
    
    
    
73. HAYEK S, Shaham G, Ben-Shlomo Y, Kepten E, et al
    Indirect protection of children from SARS-CoV-2 infection through parental vaccination.
    Science. 2022 Jan 27:eabm3087. doi: 10.1126/science.abm3087.
    PubMed     Abstract available
    
    
    
74. PRUNAS O, Warren JL, Crawford FW, Gazit S, et al
    Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel.
    Science. 2022 Jan 27:eabl4292. doi: 10.1126/science.abl4292.
    PubMed     Abstract available
    
    
    
75. WADMAN M
    Studies reveal dangers of SARS-CoV-2 infection in pregnancy.
    Science. 2022;375:253.
    PubMed     Abstract available
    
    
    
76. MANNAR D, Saville JW, Zhu X, Srivastava SS, et al
    SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex.
    Science. 2022 Jan 20:eabn7760. doi: 10.1126/science.abn7760.
    PubMed     Abstract available
    
    
    
77. MUIK A, Lui BG, Wallisch AK, Bacher M, et al
    Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.
    Science. 2022 Jan 18:eabn7591. doi: 10.1126/science.abn7591.
    PubMed     Abstract available
    
    
    
78. KAISER J
    Study of soldiers implicates common virus as MS trigger.
    Science. 2022;375:133.
    PubMed     Abstract available
    
    
    
79. OPENSHAW PJM
    Using correlates to accelerate vaccinology.
    Science. 2022;375:22-23.
    PubMed     Abstract available
    
    
    
80. LENTZOS F, Rybicki EP, Engelhard M, Paterson P, et al
    Eroding norms over release of self-spreading viruses.
    Science. 2022;375:31-33.
    PubMed     Abstract available
    
    
    
81. KUPFERSCHMIDT K, Vogel G
    Omicron threat remains fuzzy as cases explode.
    Science. 2022;375:9-10.
    PubMed     Abstract available
    
    
    December 2021
82. GUPTA RK, Topol EJ
    COVID-19 vaccine breakthrough infections.
    Science. 2021;374:1561-1562.
    PubMed     Abstract available
    
    
    
83. COHEN J
    Will global vaccine shortfalls end in 2022?
    Science. 2021;374:1546.
    PubMed     Abstract available
    
    
    
84. COHEN J
    Omicron sparks a vaccine strategy debate.
    Science. 2021;374:1544-1545.
    PubMed     Abstract available
    
    
    
85. VOGEL G, Kupferschmidt K
    Early lab studies shed light on Omicron's behavior.
    Science. 2021;374:1543-1544.
    PubMed     Abstract available
    
    
    
86. CERNUSCHI T, Malvolti S, Downham M, Maugeais D, et al
    COVID-19 impact on infant and adolescent vaccine supplies.
    Science. 2021;374:1438-1441.
    PubMed     Abstract available
    
    
    
87. KUPFERSCHMIDT K
    Missed shots.
    Science. 2021;374:1434-1435.
    PubMed     Abstract available
    
    
    
88. KUPFERSCHMIDT K
    Scientists see a 'really, really tough winter' with Omicron.
    Science. 2021;374:1421-1422.
    PubMed     Abstract available
    
    
    
89. KUPFERSCHMIDT K, Vogel G
    How bad is Omicron? Some clues are emerging.
    Science. 2021;374:1304-1305.
    PubMed     Abstract available
    
    
    
90. KUPFERSCHMIDT K
    Where did 'weird' Omicron come from?
    Science. 2021;374:1179.
    PubMed    
    
    
    
91. REYNOLDS CJ, Gibbons JM, Pade C, Lin KM, et al
    Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.
    Science. 2021 Dec 2:eabm0811.
    PubMed     Abstract available
    
    
    
92. NABEL KG, Clark SA, Shankar S, Pan J, et al
    Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain.
    Science. 2021 Dec 2:eabl6251.
    PubMed     Abstract available
    
    
    November 2021
93. GILBERT PB, Montefiori DC, McDermott AB, Fong Y, et al
    Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
    Science. 2021 Nov 23:eab3435.
    PubMed     Abstract available
    
    
    
94. WADMAN M
    To fight Lyme disease, vaccine targets ticks.
    Science. 2021;374:925.
    PubMed     Abstract available
    
    
    
95. GERBER JS, Offit PA
    COVID-19 vaccines for children.
    Science. 2021;374:913.
    PubMed     Abstract available
    
    
    
96. NORMILE D
    'Zero COVID' is getting harder-but China is sticking with it.
    Science. 2021;374:924.
    PubMed     Abstract available
    
    
    
97. JECKER NS
    Cash incentives, ethics, and COVID-19 vaccination.
    Science. 2021;374:819-820.
    PubMed     Abstract available
    
    
    
98. MCCALLUM M, Walls AC, Sprouse KR, Bowen JE, et al
    Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants.
    Science. 2021 Nov 9:eabl8506. doi: 10.1126/science.abl8506.
    PubMed     Abstract available
    
    
    
99. LADHANI SN
    Children and COVID-19 in schools.
    Science. 2021;374:680-682.
    PubMed     Abstract available
    
    
    
100. COHN BA, Cirillo PM, Murphy CC, Krigbaum NY, et al
     SARS-CoV-2 vaccine protection and deaths among US veterans during 2021.
     Science. 2021 Nov 4:eabm0620. doi: 10.1126/science.abm0620.
     PubMed     Abstract available
     
     
     
101. ELLIOTT P, Haw D, Wang H, Eales O, et al
     Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.
     Science. 2021 Nov 2:eabl9551. doi: 10.1126/science.abl9551.
     PubMed     Abstract available
     
     
     October 2021
102. KRISHTEL P, Hassan F
     Share vaccine know-how.
     Science. 2021;374:379.
     PubMed     Abstract available
     
     
     
103. ROBERTS L
     Polio vaccination to resume across Afghanistan.
     Science. 2021;374:382.
     PubMed     Abstract available
     
     
     
104. CORBETT KS, Gagne M, Wagner DA, O' Connell S, et al
     Protection against SARS-CoV-2 beta variant in mRNA-1273 vaccine-boosted nonhuman primates.
     Science. 2021 Oct 21:eabl8912. doi: 10.1126/science.abl8912.
     PubMed     Abstract available
     
     
     
105. VOGEL G
     WHO gives first malaria vaccine the green light.
     Science. 2021;374:245-246.
     PubMed     Abstract available
     
     
     
106. GOEL RR, Painter MM, Apostolidis SA, Mathew D, et al
     mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.
     Science. 2021 Oct 14:eabm0829. doi: 10.1126/science.abm0829.
     PubMed     Abstract available
     
     
     
107. CAMPOS-MERCADE P, Meier AN, Schneider FH, Meier S, et al
     Monetary incentives increase COVID-19 vaccinations.
     Science. 2021 Oct 7:eabm0475. doi: 10.1126/science.abm0475.
     PubMed     Abstract available
     
     
     
108. COHEN J
     New Chinese vaccine could bolster global arsenal.
     Science. 2021;374:12-13.
     PubMed     Abstract available
     
     
     September 2021
109. WADMAN M
     Israel's high case plateau may offer worrisome portent.
     Science. 2021;373:1428-1429.
     PubMed     Abstract available
     
     
     
110. WADMAN M
     SARS-CoV-2 infection confers greater immunity than shots.
     Science. 2021;373:1067-1068.
     PubMed     Abstract available
     
     
     August 2021
111. PINTO D, Sauer MM, Czudnochowski N, Low JS, et al
     Broad betacoronavirus neutralization by a stem helix-specific human antibody.
     Science. 2021 Aug 3. pii: science.abj3321. doi: 10.1126/science.abj3321.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.